La FDA requiere advertencias sobre riesgo de tumores de clulas C tiroideas (observados en roedores, relevancia en humanos incierta), pancreatitis, enfermedad de la vescula biliar y posible lesin renal aguda relacionada con deshidratacin por efectos gastrointestinales
Saxendas approval set a precedent in efficacy and pricing, with a cost of over $1,000 per month
The American College of Cardiology and American Heart Association guidelines do not currently recommend GLP-1 receptor agonists as primary lipid-lowering agents
Victoza (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes mellitus
They care about safe and responsible distribution of these products to advance peptide research
Your Partner in Healthy Weight Loss on GLP-1 Medications Starting Ozempic, Wegovy, or Mounjaro